Marian E Durkin

Marian E Durkin

UNVERIFIED PROFILE

Are you Marian E Durkin?   Register this Author

Register author
Marian E Durkin

Marian E Durkin

Publications by authors named "Marian E Durkin"

Are you Marian E Durkin?   Register this Author

19Publications

295Reads

36Profile Views

DNMT1 is a required genomic regulator for murine liver histogenesis and regeneration.

Hepatology 2016 08 28;64(2):582-98. Epub 2016 Apr 28.

Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.28563DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841553PMC
August 2016

Cooperative antiproliferative effect of coordinated ectopic expression of DLC1 tumor suppressor protein and silencing of MYC oncogene expression in liver cancer cells: Therapeutic implications.

Oncol Lett 2016 Aug 24;12(2):1591-1596. Epub 2016 Jun 24.

Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 2089-4262, USA; Laboratory of Cellular Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-4262, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ol.2016.4781DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4950702PMC
August 2016

DLC1 is the principal biologically-relevant down-regulated DLC family member in several cancers.

Oncotarget 2016 Jul;7(29):45144-45157

Laboratory of Cellular Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.9266DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216712PMC
July 2016

MYC activates stem-like cell potential in hepatocarcinoma by a p53-dependent mechanism.

Cancer Res 2014 Oct 4;74(20):5903-13. Epub 2014 Sep 4.

Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-14-0527DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4199878PMC
October 2014

Isolation of Mouse Embryo Fibroblasts.

Bio Protoc 2013 Sep;3(18)

Laboratory of Cellular Oncology, National Cancer Institute, NIH, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4928858PMC
http://dx.doi.org/10.21769/bioprotoc.908DOI Listing
September 2013

Modeling pathogenesis of primary liver cancer in lineage-specific mouse cell types.

Gastroenterology 2013 Jul 19;145(1):221-231. Epub 2013 Mar 19.

Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2013.03.013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913051PMC
July 2013

Inactivation of the Dlc1 gene cooperates with downregulation of p15INK4b and p16Ink4a, leading to neoplastic transformation and poor prognosis in human cancer.

Cancer Res 2012 Nov 25;72(22):5900-11. Epub 2012 Sep 25.

Laboratories of Cellular Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-12-2368DOI Listing
November 2012

DLC-1:a Rho GTPase-activating protein and tumour suppressor.

J Cell Mol Med 2007 Sep-Oct;11(5):1185-207

Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1582-4934.2007.00098.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4401278PMC
January 2008

GTF2IRD1 in craniofacial development of humans and mice.

Science 2005 Nov 3;310(5751):1184-7. Epub 2005 Nov 3.

Academic Unit of Medical Genetics, University of Manchester, St. Mary's Hospital, Manchester M13 9PL, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/science.1116142DOI Listing
November 2005

DLC-1, a Rho GTPase-activating protein with tumor suppressor function, is essential for embryonic development.

FEBS Lett 2005 Feb 19;579(5):1191-6. Epub 2005 Jan 19.

Laboratory of Experimental Carcinogenesis, National Cancer Institute, National Institutes of Health, 37 Convent Drive, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.febslet.2004.12.090DOI Listing
February 2005

SMAD5 gene expression, rearrangements, copy number, and amplification at fragile site FRA5C in human hepatocellular carcinoma.

Neoplasia 2003 Sep-Oct;5(5):390-6

Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1502609PMC
http://dx.doi.org/10.1016/s1476-5586(03)80041-6DOI Listing
July 2004

DNA variants of DLC-1, a candidate tumor suppressor gene in human hepatocellular carcinoma.

Int J Oncol 2003 Jul;23(1):133-7

Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute/NIH, 37 Convent Drive, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
July 2003

Amplification and overexpression of the EMS 1 oncogene, a possible prognostic marker, in human hepatocellular carcinoma.

J Mol Diagn 2003 Feb;5(1):48-53

Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland 20892-4258, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S152515781060451
Publisher Site
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1907373PMC
http://dx.doi.org/10.1016/S1525-1578(10)60451-5DOI Listing
February 2003

DLC-1 gene inhibits human breast cancer cell growth and in vivo tumorigenicity.

Oncogene 2003 Jan;22(3):445-50

Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.onc.1206064DOI Listing
January 2003

Promoter hypermethylation of DLC-1, a candidate tumor suppressor gene, in several common human cancers.

Cancer Genet Cytogenet 2003 Jan;140(2):113-7

Health Effects Laboratory Division, Toxicology and Molecular Biology Branch, National Institute for Occupational Safely and Health, Morgantown, WV 26505, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0165-4608(02)00674-xDOI Listing
January 2003

Gene structure, tissue expression, and linkage mapping of the mouse DLC-1 gene (Arhgap7).

Gene 2002 Apr;288(1-2):119-27

Laboratory of Experimental Carcinogenesis, Building 37, Room 3C28, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0378-1119(02)00462-6DOI Listing
April 2002